| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $342.4M | $367.3M | $320.0M |
| YoY Revenue Growth % | -6.8% | +14.8% | — |
| Gross Profit | $271.3M | $317.1M | — |
| Gross Margin % | 79.2% | 86.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$841.0K | $27.9M | $56.0M |
| Operating Margin % | -0.2% | 7.6% | 17.5% |
| Net Income (GAAP) | $3.6M | $68.7M | $38.1M |
| EBITDA (Normalized) | $15.4M | $28.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $95.3M | $115.9M | $22.7M |
| Capital Expenditures (CapEx) | $20.3M | $871.0K | — |
| Free Cash Flow (FCF) | $75.0M | $115.0M | $22.7M |
| FCF Margin % | 21.9% | 31.3% | 7.1% |
| Return on Invested Capital (ROIC %) | -0.7% | 20.4% | — |
| Cash & Short-Term Equivalents | $186.6M | $349.3M | — |
| Total Debt (Short + Long Term) | — | $0 | — |
| Total Stockholders' Equity | $287.7M | $457.3M | — |